Table 2.
Genotypic and allelic frequencies of R219K, C69T, and R230C, respectively, according to subjects.
| T2DM (%) | (95% CI) | Controls (%) | P value | ||
|---|---|---|---|---|---|
| R219K | GG | 94 (57.3%) | 56 (33.9%) | ||
| Genotypes and alleles | GA | 55 (33.5%) | 77 (46.6%) | 0.000* | |
| AA | 15 (9.1%) | 32 (19.3%) | |||
| Alleles | G | 243 (74%) | 189 (57.2%) | 0.000* | |
| A | 85 (26%) | 141 (42.8%) | |||
|
| |||||
| GG versus GA | 0.07–0.34 | 0.001* | |||
| Post hoc test | GG versus AA | 0.11–0.49 | 0.001* | ||
| GA versus AA | −0.09–0.29 | 0.467 | |||
|
| |||||
| C69T | CC | 65 (39.6%) | 83 (50.3%) | ||
| Genotypes and alleles | CT | 48 (29.2%) | 48 (29%) | NS | |
| TT | 51 (31%) | 34 (20.6%) | |||
| C | 154 (54.2%) | 190 (64.8%) | 0.005* | ||
| Alleles | T | 150 (45.8%) | 116 (35.2%) | ||
|
| |||||
| CC versus CT | −0.18–0.06 | 0.352 | |||
| Post hoc test | CC versus TT | −0.29–−0.02 | 0.018* | ||
| CT versus TT | −0.24–0.04 | 0.179 | |||
|
| |||||
| R230C | CC | 69 (42%) | 64 (38.7%) | ||
| Genotypes and alleles | CT | 72 (43.6%) | 67 (40.6%) | NS | |
| TT | 32 (19.3%) | 34 (20.6%) | |||
| C | 210 (63.9%) | 195 (59%) | 0.695 | ||
| Alleles | T | 136 (36.1%) | 135 (41%) | ||
|
| |||||
| CC versus CT | 0.11-0.12 | 0.989 | |||
| Post hoc test | CC versus TT | −0.04–0.27 | 0.147 | ||
| CT versus TT | −0.04–0.26 | 0.147 | |||
* P < 0.05.